Form 4: Pressure BioSciences Director Acquires Shares Through Interest Payment

Director Jeffrey N. Peterson acquired 59,652 shares of Pressure BioSciences Inc. (PBIO) common stock on September 27, 2024, through interest paid on convertible preferred stock.

Summary

• On September 27, 2024, Jeffrey N. Peterson, a director of Pressure BioSciences Inc. (PBIO), acquired 59,652 shares of common stock.
• The acquisition was a result of interest paid on convertible preferred stock.
• The price per share was $0.028.
• Following the transaction, Peterson directly owns 142,084 shares of PBIO common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to interest payment. The director increasing their stake is mildly positive, but it's not a significant market-moving event.

Positives

• Director's acquisition of shares may signal confidence in the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be indicative of their confidence in the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director increasing their stake in the company.

Key Dates

Keywords

Pressure BioSciences Inc, PBIO, Jeffrey N. Peterson, Director, Share Acquisition, Common Stock, Convertible Preferred Stock, Form 4, Insider Trading